Key statistics
As of last trade, Cytek Biosciences Inc (8EQ:MUN) traded at 6.15, 43.02% above the 52 week low of 4.30 set on Sep 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.15 |
---|---|
High | 6.15 |
Low | 6.15 |
Bid | 6.35 |
Offer | 6.40 |
Previous close | 5.80 |
Average volume | 277.78 |
---|---|
Shares outstanding | 128.81m |
Free float | 117.47m |
P/E (TTM) | -- |
Market cap | 832.12m USD |
EPS (TTM) | -0.0782 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:02 GMT.
More ▼
Announcements
- Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
- Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
- Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
- Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
- Cytek Biosciences Announces $50 Million Stock Repurchase Program
- Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
- 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
- Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
- Cytek Biosciences Reports First Quarter 2024 Financial Results
More ▼